New York State Common Retirement Fund
PLX icon

New York State Common Retirement Fund’s Protalix BioTherapeutics PLX Stock Holding History

New York State Common Retirement Fund’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.5K Hold
31,100
– – ﹤0.01% 2848
2026
Q1 		$67.5K Hold
31,100
– – ﹤0.01% 2710
2025
Q4 		$56K Sell
31,100
-10,200
-25% -$20.9K ﹤0.01% 2875
2025
Q3 		$91.7K Sell
41,300
-27,700
-40% -$45.1K ﹤0.01% 2664
2025
Q2 		$102K Buy
+69,000
New +$141K ﹤0.01% 2621
2024
Q3 		– Sell
-555
Closed -$649 – 3305
2024
Q2 		$649 Sell
555
-45,100
-99% -$53.3K ﹤0.01% 3316
2024
Q1 		$57.5K Buy
45,655
+555
+1% +$829 ﹤0.01% 2943
2023
Q4 		$80.3K Sell
45,100
-700
-2% -$1.09K ﹤0.01% 2830
2023
Q3 		$76K Buy
45,800
+700
+2% +$1.26K ﹤0.01% 2855
2023
Q2 		$90.2K Buy
+45,100
New +$107K ﹤0.01% 2944

Other funds holding PLX

SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HIM
Harbour Investment Management Edmonds, Washington $194M AUM 15.93% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
OGF
Orin Green Financial San Diego, California $271M AUM 20.78% 1-Year Est. Return

New York State Common Retirement Fund's PLX Position: Q2 2026 in Review

New York State Common Retirement Fund held its Protalix BioTherapeutics (PLX) position steady in Q2 2026 at 31,100 shares worth $72.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

New York State Common Retirement Fund first reported a position in PLX in Q2 2023 and has held it in 10 quarters since. The position peaked at $102K in Q2 2025. 22 funds tracked by Wall St. Rank hold PLX as of Q2 2026.

  • New York State Common Retirement Fund held 31,100 shares of Protalix BioTherapeutics worth $72.5K as of Q2 2026.
  • New York State Common Retirement Fund left its Protalix BioTherapeutics share count unchanged in Q2 2026.
  • Protalix BioTherapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2848 holding.
  • New York State Common Retirement Fund first reported a position in Protalix BioTherapeutics in Q2 2023 and has held it in 10 quarters since.
  • New York State Common Retirement Fund's Protalix BioTherapeutics position peaked at $102K in Q2 2025.
  • 22 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.